SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-017379
Filing Date
2024-01-29
Accepted
2024-01-29 07:15:03
Documents
16
Period of Report
2024-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d683269d8k.htm   iXBRL 8-K 32127
2 EX-99.1 d683269dex991.htm EX-99.1 11780
6 GRAPHIC g683269g0129053049454.jpg GRAPHIC 3627
  Complete submission text file 0001193125-24-017379.txt   178900

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20240124.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20240124_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20240124_pre.xml EX-101.PRE 11255
17 EXTRACTED XBRL INSTANCE DOCUMENT d683269d8k_htm.xml XML 3637
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 24570080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)